Skip to main content

Advertisement

SpringerLink
Log in

Platelet Lysate and Granulocyte-Colony Stimulating Factor Serve Safe and Accelerated Expansion of Human Bone Marrow Stromal Cells for Stroke Therapy

  • Original Article
  • Published:
Translational Stroke Research Aims and scope Submit manuscript

Abstract

Autologous human bone marrow stromal cells (hBMSCs) should be expanded in the animal serum-free condition within clinically relevant periods in order to secure safe and effective cell therapy for ischemic stroke. This study was aimed to assess whether the hBMSCs enhance their proliferation capacity and provide beneficial effect in the infarct brain when cultured with platelet lysate (PL) and granulocyte-colony stimulating factor (G-CSF). The hBMSCs were cultured in the fetal calf serum (FCS)-, PL-, or PL/G-CSF-containing medium. Cell growth kinetics was analyzed. The hBMSCs-PL, hBMSC-PL/G-CSF, or vehicle was stereotactically transplanted into the ipsilateral striatum of the rats subjected to permanent middle cerebral artery occlusion 7 days after the insult. Motor function was assessed for 8 weeks, and the fate of transplanted hBMSCs was examined using immunohistochemistry. As the results, the hBMSCs-PL/G-CSF showed more enhanced proliferation than the hBMSCs-FCS and hBMSCs-PL. Transplantation of hBMSCs expanded with the PL- or PL/G-CSF-containing medium equally promoted functional recovery compared with the vehicle group. Histological analysis revealed that there were no significant differences in their migration, survival, and neural differentiation in the infarct brain between the hBMSCs-PL and hBMSCs-PL/G-CSF. These findings strongly suggest that the combination of PL and G-CSF may accelerate hBMSC expansion and serve safe cell therapy for patients with ischemic stroke at clinically relevant timing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats–similarities to astrocyte grafts. Proc Natl Acad Sci U S A. 1998;95:3908–13.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A. 1999;96:10711–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Abe K, Yamashita T, Takizawa S, Kuroda S, Kinouchi H, Kawahara N. Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab. 2012;32:1317–31.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Kuroda S. Bone marrow stromal cell transplantation for ischemic stroke—its multi-functional feature. Acta Neurobiol Exp (Wars). 2013;73:57–65.

    Google Scholar 

  5. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol. 2010;223:229–37.

    Article  PubMed  CAS  Google Scholar 

  6. Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, et al. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy. 2009;11:897–911.

    Article  PubMed  CAS  Google Scholar 

  7. Zhang ZX, Guan LX, Zhang K, Zhang Q, Dai LJ. A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy. 2008;10:134–9.

    Article  PubMed  CAS  Google Scholar 

  8. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874–82.

    Article  PubMed  Google Scholar 

  9. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010;28:1099–106.

    Article  PubMed  Google Scholar 

  10. Ito M, Kuroda S, Sugiyama T, Shichinohe H, Takeda Y, Nishio M, et al. Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats—a serial MRI study. Transl Stroke Res. 2011;2:294–306.

    Article  PubMed  Google Scholar 

  11. Shichinohe H, Kuroda S, Sugiyama T, Ito M, Kawabori M, Nishio M, et al. Biological features of human bone marrow stromal cells (hBMSC) cultured with animal protein-free medium—safety and efficacy of clinical use for neurotransplantation. Transl Stroke Res. 2011;2:307–15.

    Article  PubMed  CAS  Google Scholar 

  12. Sugiyama T, Kuroda S, Takeda Y, Nishio M, Ito M, Shichinohe H, et al. Therapeutic impact of human bone marrow stromal cells expanded by animal serum-free medium for cerebral infarct in rats. Neurosurgery. 2011;68:1733–42.

    Article  PubMed  Google Scholar 

  13. Kawabori M, Kuroda S, Ito M, Shichinohe H, Houkin K, Kuge Y, et al. Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology. 2013;33:140–8.

    Article  PubMed  CAS  Google Scholar 

  14. Chiba Y, Kuroda S, Osanai T, Shichinohe H, Houkin K, Iwasaki Y. Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF). Neuropathology. 2012;32:139–48.

    Article  PubMed  Google Scholar 

  15. Hokari M, Kuroda S, Chiba Y, Maruichi K, Iwasaki Y. Synergistic effects of granulocyte-colony stimulating factor on bone marrow stromal cell transplantation for mice cerebral infarct. Cytokine. 2009;46:260–6.

    Article  PubMed  CAS  Google Scholar 

  16. Kawabori M, Kuroda S, Sugiyama T, Ito M, Shichinohe H, Houkin K, et al. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology. 2012;32:217–26.

    Article  PubMed  Google Scholar 

  17. Miyamoto M, Kuroda S, Zhao S, Magota K, Shichinohe H, Houkin K, et al. Bone marrow stromal cell transplantation enhances recovery of local glucose metabolism after cerebral infarction in rats: a serial 18F-FDG PET study. J Nucl Med. 2013;54:145–50.

    Article  PubMed  CAS  Google Scholar 

  18. Shichinohe H, Kuroda S, Lee JB, Nishimura G, Yano S, Seki T, et al. In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Res Protocol. 2004;13:166–75.

    Article  Google Scholar 

  19. Shichinohe H, Kuroda S, Yano S, Hida K, Iwasaki Y. Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct. Brain Res. 2007;1183:138–47.

    Article  PubMed  CAS  Google Scholar 

  20. Meuleman N, Tondreau T, Delforge A, Dejeneffe M, Massy M, Libertalis M, et al. Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol. 2006;76:309–16.

    Article  PubMed  Google Scholar 

  21. Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol. 2007;213:18–26.

    Article  PubMed  CAS  Google Scholar 

  22. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007;47:1436–46.

    Article  PubMed  CAS  Google Scholar 

  23. Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med. 2008;2:472–81.

    Article  PubMed  CAS  Google Scholar 

  24. Perez-Ilzarbe M, Diez-Campelo M, Aranda P, Tabera S, Lopez T, del Canizo C, et al. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion. 2009;49:1901–10.

    Article  PubMed  CAS  Google Scholar 

  25. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205:228–36.

    Article  PubMed  CAS  Google Scholar 

  26. van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng. 2006;12:3067–73.

    Article  PubMed  Google Scholar 

  27. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295–307.

    Article  PubMed  CAS  Google Scholar 

  28. Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A, et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007;40:785–91.

    Article  PubMed  CAS  Google Scholar 

  29. Welte K, Platzer E, Gabrilove JL, Lu L, Levi E, Polivka A, et al. Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Haematol Blood Transfus. 1985;29:398–401.

    PubMed  CAS  Google Scholar 

  30. Kuroda S, Houkin K. Translational challenge for bone marrow stromal cell therapy after stroke. Front Neurol Neurosci. 2013;32:62–8.

    Article  PubMed  Google Scholar 

  31. Savitz SI, Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann Neurol. 2007;61:396–402.

    Article  PubMed  CAS  Google Scholar 

  32. Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30:2752–8.

    Article  Google Scholar 

  33. The STEPS Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40:510–5.

    Article  Google Scholar 

  34. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A. 2002;99:2199–204.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  35. Bakshi A, Barshinger AL, Swanger SA, Madhavani V, Shumsky JS, Neuhuber B, et al. Lumbar puncture delivery of bone marrow stromal cells in spinal cord contusion: a novel method for minimally invasive cell transplantation. J Neurotrauma. 2006;23:55–65.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Grant-in-Aids from the Ministry of Education, Science and Culture of Japan (No.21390400, No.233390342 and No.25293305).

Conflict of Interest

Tomohiro Yamauchi, Hisayasu Saito, Masaki Ito, Hideo Shichinohe, Kiyohiro Houkin, and Satoshi Kuroda declare that they have no conflict of interest.

Compliance with Ethics Requirements

All institutional and national guidelines for the care and use of laboratory animals were followed.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    Tomohiro Yamauchi, Hisayasu Saito, Masaki Ito, Hideo Shichinohe, Kiyohiro Houkin & Satoshi Kuroda

  2. Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan

    Satoshi Kuroda

Authors
  1. Tomohiro Yamauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisayasu Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaki Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideo Shichinohe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiyohiro Houkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Satoshi Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoshi Kuroda.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamauchi, T., Saito, H., Ito, M. et al. Platelet Lysate and Granulocyte-Colony Stimulating Factor Serve Safe and Accelerated Expansion of Human Bone Marrow Stromal Cells for Stroke Therapy. Transl. Stroke Res. 5, 701–710 (2014). https://doi.org/10.1007/s12975-014-0360-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12975-014-0360-z

Keywords

Search

Navigation